Atlas Trials

Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock

Clinical trial NCT06556472 · UNKNOWN

Trial details

NCT number
NCT06556472
Sponsor
Institute of Liver and Biliary Sciences, India
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute on Chronic Liver Failure
Start date
2024-08-15
Primary completion
2025-08-31
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.